Literature DB >> 18264130

Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation.

P Meijer1, C W Wouters, P H H van den Broek, G J Scheffer, N P Riksen, P Smits, G A Rongen.   

Abstract

BACKGROUND AND
PURPOSE: Dipyridamole enhances post-occlusive reactive hyperaemia (PORH) in the human forearm vascular bed. We hypothesize that this effect is completely mediated by increased adenosine receptor stimulation. To test this hypothesis, the effect of caffeine (an adenosine receptor antagonist) on dipyridamole-induced augmentation of PORH was explored. EXPERIMENTAL APPROACH: The forearm vasodilator responses to three increasing periods of forearm ischaemia (2, 5 and 13 min) were determined during placebo infusion. Forty minutes after the last reperfusion period, this procedure was repeated during intra-arterial infusion of dipyridamole (7.4 nmol min(-1) per 100 ml forearm). At least 2 weeks later, this whole procedure was repeated, but now in the presence of caffeine (90 microg min(-1) per 100 ml volume). KEY
RESULTS: After 2, 5 and 13 min of ischaemia, the average forearm blood flow increased to 5.6+/-0.7, 9.7+/-1.3 and 34.5+/-2.1 ml min(-1) per 100 ml. After infusion of dipyridamole into the brachial artery, these numbers were significantly increased to 7.7+/-0.8, 12.5+/-1.5 and 41.6+/-3.1 ml min(-1) per 100 ml. This response was abolished by the concomitant infusion of caffeine (6.6+/-0.5, 10.2+/-0.6, 35.1+/-2.2 (caffeine) versus 7.4+/-0.4, 10.5+/-0.6, 33.7+/-2.2 ml min(-1)per 100 ml (caffeine/dipyridamole)). CONCLUSIONS AND IMPLICATIONS: Caffeine prevented the augmenting effect of dipyridamole on PORH. This indicates that dipyridamole-induced augmentation of PORH is mediated via increased adenosine receptor stimulation as a result of elevated extracellular formation of adenosine during ischaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264130      PMCID: PMC2275438          DOI: 10.1038/bjp.2008.10

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

Review 1.  The role of adenosine in preconditioning.

Authors:  J W de Jong; R de Jonge; E Keijzer; S Bradamante
Journal:  Pharmacol Ther       Date:  2000 Aug-Sep       Impact factor: 12.310

2.  CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation.

Authors:  Alma Zernecke; Kiril Bidzhekov; Burcin Ozüyaman; Line Fraemohs; Elisa A Liehn; Juliane M Lüscher-Firzlaff; Bernhard Lüscher; Jürgen Schrader; Christian Weber
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

3.  Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.

Authors:  Niels P Riksen; Barbara Franke; Wim J G Oyen; George F Borm; Petra van den Broek; Otto C Boerman; Paul Smits; Gerard A Rongen
Journal:  Eur Heart J       Date:  2007-03-21       Impact factor: 29.983

4.  In vivo evidence against a role for adenosine in the exercise pressor reflex in humans.

Authors:  Niels P Riksen; Egidia E M van Ginneken; Petra H H van den Broek; Paul Smits; Gerard A Rongen
Journal:  J Appl Physiol (1985)       Date:  2005-04-07

5.  Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning.

Authors:  U E Heidland; M P Heintzen; C J Michel; B E Strauer
Journal:  Coron Artery Dis       Date:  2000-12       Impact factor: 1.439

6.  Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase.

Authors:  C Gardner; N Robas; D Cawkill; M Fidock
Journal:  Biochem Biophys Res Commun       Date:  2000-05-27       Impact factor: 3.575

7.  Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole.

Authors:  Alfredo Gamboa; Robert Abraham; Andre Diedrich; Cyndya Shibao; Sachin Y Paranjape; Ginnie Farley; Italo Biaggioni
Journal:  Stroke       Date:  2005-09-01       Impact factor: 7.914

8.  Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release.

Authors:  U K Decking; G Schlieper; K Kroll; J Schrader
Journal:  Circ Res       Date:  1997-08       Impact factor: 17.367

9.  Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors.

Authors:  D A Liem; M A van den Doel; S de Zeeuw; P D Verdouw; D J Duncker
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

10.  Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.

Authors:  Gerard A Rongen; Wim J G Oyen; Bart P Ramakers; Niels P Riksen; Otto C Boerman; Neil Steinmetz; Paul Smits
Journal:  Circulation       Date:  2004-12-27       Impact factor: 29.690

View more
  7 in total

1.  Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease.

Authors:  Patricia Ann Shi; Deepa Manwani; Olugbenga Olowokure; Vijay Nandi
Journal:  Blood Cells Mol Dis       Date:  2014-05-21       Impact factor: 3.039

2.  Reactive hyperemia occurs via activation of inwardly rectifying potassium channels and Na+/K+-ATPase in humans.

Authors:  Anne R Crecelius; Jennifer C Richards; Gary J Luckasen; Dennis G Larson; Frank A Dinenno
Journal:  Circ Res       Date:  2013-08-12       Impact factor: 17.367

3.  The effect of antecedent hypoglycaemia on β₂-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the β₂-adrenergic receptor.

Authors:  B J J W Schouwenberg; P Smits; C J Tack; B E de Galan
Journal:  Diabetologia       Date:  2011-02-06       Impact factor: 10.122

4.  The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.

Authors:  T N A van den Berg; Jaap Deinum; Albert Bilos; A Rogier T Donders; Gerard A Rongen; Niels P Riksen
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

5.  Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo.

Authors:  T N A van den Berg; S El Messaoudi; G A Rongen; P H H van den Broek; A Bilos; A R T Donders; M E Gomes; N P Riksen
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

6.  Adenosine Receptor Activation in the "Trigger" Limb of Remote Pre-Conditioning Mediates Human Endothelial Conditioning and Release of Circulating Cardioprotective Factor(s).

Authors:  Hussain Contractor; Rasmus Haarup Lie; Colin Cunnington; Jing Li; Nicolaj B Støttrup; Cedric Manlhiot; Hans Erik Bøtker; Michael R Schmidt; J Colin Forfar; Houman Ashrafian; Andrew Redington; Rajesh K Kharbanda
Journal:  JACC Basic Transl Sci       Date:  2016-09-28

7.  Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia-reperfusion injury: A prospective case-control study.

Authors:  T N A Daniëlle van den Berg; Dick H J Thijssen; Anke C C M van Mil; Petra H van den Broek; Gerard A Rongen; Houshang Monajemi; Jaap Deinum; Niels P Riksen
Journal:  Eur J Clin Invest       Date:  2019-11-25       Impact factor: 4.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.